Human T-lymphotropic virus type I infection and idiopathic thrombocytopnic purpura

Hematology

Volumn 10, Issue 2, 2005, Pages 95-99

  Matsushita, Kakushi ^a   Ozaki, Atsuo ^a   Arima, Naomichi ^b   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Helicobacter pylori; HTLV I; ITP; Prednisolone; Splenectomy

Indexed keywords

ANTIVIRUS AGENT; PREDNISOLONE;

ARTICLE; COMORBIDITY; DISEASE ASSOCIATION; ERADICATION THERAPY; HELICOBACTER INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; IDIOPATHIC THROMBOCYTOPENIC PURPURA; PREVALENCE; PRIORITY JOURNAL; SPINAL CORD DISEASE; SPLENECTOMY; STEROID THERAPY; T CELL LEUKEMIA; THROMBOCYTOPENIA; TREATMENT OUTCOME; ADULT; AGED; FEMALE; HELICOBACTER PYLORI; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MALE; MICROBIOLOGY; MIDDLE AGED; VIROLOGY;

ADULT; AGED; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 24644508993     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330500065714     Document Type: Article

References (43)

1. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterizaiton of retrovirus (ATLV) from cell line of adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci 1982;79:2031-2035.
2. Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A. Chronic progressive myelopathy associated with elevated antibodies to human lymphotropic virus type-I and adult T-cell leukemia-like cells. Ann Neurol 1987;21:117-122.
3. Kawai H, Inui T, Kashiwagi S, Tsuchihashi T, Masuda K, Kondo A, Niki S, Iwasa M, Saito M. HTLV-I infection in patients with autoimmune thyroiditis (Hashimoto's thyroidids). J Med Virol 1992;38:138-142.
4. Mochizuki M, Watanabe T, Yamaguchi K, Takatsuki K, Yoshimura K, Shirao M, Nakashima S, Mori S, Araki S, Miyama N. HTLV-I uveitis: A distinct clinical entity caused by HTLV-I. Japan J Cancer Res 1992;83:236-239.
5. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1989;i:441.
6. Morgan OS, Rodgers-Johnson P, Mora C, Char G. HTLV-I and polymyositis in Jamaica. Lancet 1989;ii:992-995.
7. Tsukasaki K, Koba T, Iwanaga M, Murata K, Maeda T, Atogami S, Nakamura H, Yamada Y, Kamihira S, Tomonaga M. Possible association between adult T-cell leukemia/lymphoma and acute myeloid leukemia. Cancer 1998; 82:488-494.
8. Karlic H, Mostl M, Mucke H, Pavlova B, Pfeilstocker M, Heinz R. Association of human T-cell leukemia virus and myelodysplastic syndrome in a central European population. Cancer Res 1997;57:4718-4721.
9. Matsuoka T, Tamura H, Fujishita M, Kubonishi I, Taguchi H, Miyoshi I. Thrombocytopenia in a carrier of human T-cell leukemia virus type I. Am J Hematol 1988;27:142-143.
10. Seiki M, Hattori S, Hirayama Y, Yoshida M. Human adult T cell leukemia virus: Complete nucleotide sequence of the provirus genome integrated in leukemic cell DNA. Proc Natl Acad Sci USA 1980;80:6899-6902.
11. Seiki M, Eddy R, Shows TB, Yoshida M. Nonspecific integration of the HTLV provirus genome into adult T-cell leukemia cells. Nature 1984;309:640-642.
12. Seikevitz M, Feinberg MB, Holbrook N, Wong SF, Green WC. Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the transactivator (tat) gene product of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1987;84:5389-5393.
13. Fujii M, Coris P, Verma I. c-fos promotor trans-activation by the taxi protein of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1988;85:8526-8530.
14. Shirakawa F, Tanaka Y, Oda S, Eto S, Yamashita U. Autocrine stimulation of interleukin 1 alpha in the growth of adult human T-cell leukemia cells. Cancer Res 1989;49:1143-1147.
15. Arima N, Daitoku Y, Yamamoto Y, Fujimoto K, Ohgaki S, Kojima K, Fukumori J, Matsushita K, Tanaka H, Onoue K. Heterogeneity in response to interleukin-2 and interleukin-2-producing ability of adult T cell leukemia cells. J Immunol 1987;138:3069-3074.
16. Uchiyama T, Kamio M, Kodaka T, Tamori S, Fukuhara S, Amakawa R, Uchino H, Arai K. Leukemic cells from some adult T-cell leukemia patients proliferate in response to interleukin-4. Blood 1988;72:1182-1186.
17. Matsushita K, Arima N, Ohtsubo H, Fujiwara H, Hidaka S, Fukumori J, Tanaka H. Frequent expression of interleukin-9 messenger RNA and infrequent involvement of interleukin-9 in proliferation of primary tumor cells and established T cell lines of adult T cell leukemia. Leukemia Res 1997;21:211-216.
18. Matsushita K, Arima N, Yamagushi K, Matsusmoto T, Ohtsubo H, Hidaka S, Fujiwara H, Arimura K, Kukita T, Tokito Y, Ozaki A, Tei C. Granulocyte Colonny-stimulating factor production by adult T-cell leukemia cells. Br J Haematol 2000;111:208-215.
19. Hashimoto K, Higuchi I, Osame M, Izumo S. Quantitative in situ PCR assay of HTLV-I infected cells in peripheral blood lymphocytes of patients with ATL, HAM/TSP and asymptomatic carriers. J Neurol Sci 1998;159:67-72.
20. Tajima K. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: Estimates of risk of ATL and its geographic and cliinical features. The T- and B-cell Malignancy Study Group. Int J Cancer 1990;45:237-244.
21. Furukawa Y, Fujisawa J, Osame M, Toita M, Sonoda S, Kubota R, Ijichi S, Yoshida M. Frequent clonal proliferation of human T-cell leukemia virus type 1 (HTLV-1)-infected T cells in HTLV-1-associated myelopathy (HAM-TSP). Blood 1992;80:1012-1016.
22. George NJ, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballen PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I. Idiopathic thrombocytopenic purpura: A practical guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40.
23. Berchtold P, Harris JP, Tani P, et al. Autoantibodies to platelet glycoproteins in patients with disease related immune thrombocytopenia. Br J Haematol 1989;73:365-368.
24. Kuwana M, Kaburaki J, Ikeda Y. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. J Clin Invest 1998;102:1393-1402.
25. Kaplan C, Morinet F, Carton J. Virus-induced autoimmune thrombocytopenia and neutropenia. Semin Hematol 1992;29:34-44.
26. Oski FA, Naiman JL. Effect of live measles vaccine on the platelet count. N Engl J Med 1966;275:352-356.
27. Kelton, et al. A prospective comparison of four techniques for measuring platelet-associated IgG. Br J Haematol 1989;71:97-105.
28. Abrams DI, Kiprov DD, Goedart JJ, Sarngadharan MG, Gallo RC, Volberding PA. Antibodies to human T-lymphotropic virus type III and development of the acquired immunodeficiency syndrome in homosexual men presenting with immunecytopenia. Ann Intern Med 1986;104:47-50.
29. Scradovou A. HIV-related thrombocytopenia. Blood Rev 2002;16:73-74.
30. Caso JAA, Mingo CS, Tena JG. Highly active antiretroviral therapy on thrombocytopenia in patients with HIV infection. N Engl J Med 1999;341:1239-1240.
31. Kellner SV, McGrath KM, Street AM. Management of human immunodeficiency virus-induced thrombocytopenia in hemophilia. Aust NZ J Med 1987;17:581-584.
32. Kurtzberg J, Friedman HS, Kinney TR, Chaffee S, Steine K, Falletta JM, Weinhold KJ. Management of human immunodeficiency virus-associated thrombocytopenia with intravenous gamma globulin. Am J Pediatr Hematol Oncol 1987;9:299-301.
33. Scaradavou A, Woo B, Woloski BMR, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JM. Intravenous anti-D treatment of immune thrombocytopenic purpura: Evidence in 272 patients. Blood 1997;89:2689-2700.
34. Ferguston CM. Splenectomy for immune thrombocytopenia related to human immunodeficiency virus. Surg Gynecol Obstet 1988;167:300-302.
35. Matsuoka T, Tamura H, Fujishita M, Kubonishi I, Taguchi H, Miyoshi I. Thrombocytopenia in a carrier of human T-cell leukemia virus type I. Am J Hematol 1988;27:142-143.
36. Scott TF, Goust JM, Strange CB, Brillman J. SLE, thrombocytopenia, HTLV-I. J Rheumatol 1990;17: 1655-1656.
37. Calleja E, Klein R, Bussel J. Is it necessary to test patients with immune thrombocytopenic purpura (ITP) for seropositivity to HTLV-I? Am J Hematol 1999;61:94-97.
38. Matsushita K, Arima N, Ohtsubo H, Fujiwara H, Arimura K, Kukita T, Ozaki A, Hidaka S, Matsumoto T, Tei C. Poor response to prednisolone of idiopathic thrombocytopenia with human T-lymphotropic virus type Iinfection. Am J Hematol 2002;71:20-23.
39. Emillia G, Longo G, Luppi M, Gandlini G, Morselli M, Ferrara L, Amarri S, Gagossi K, Torelli G. Helicobacter pyroli eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 2001;97:812-814.
40. Kumagai T, Sekigawa K, Hashimoto N, Shirato R. Remission of idiopathic thrombocytopenic purpura by eradicating Helicobactor pyroli after omeprazol monotherapy. Int J Hematol 2001;74:237-238.
41. Jarque I, Andreu I, Llopis I, De La Rubia J, Gomis F, Senent L, Jimenez C, Martin G, Martinez JA, Sanz GF, Ponce J, Sanz MA. Absence of platelet response after eradication of Helicobacter pyroli infection in patients with idiopathic thrombocytopenic purpura. Br J Haematol 2001;115: 1002-1003.
42. Isomoto H, Mizuta Y, Fukushima K, et al. Low prevalence of Helicobacter pyroli in individuals with HTLV-I infection. Eur J Gatroenterol Hepatol 1999;11:497-502.
43. Byme MF, Kerrigan SW, Corcoran PA, Atherton JC, Murray FE, Fitzgerald DJ, Cox DM. Helicobactor pyroli binds von Willebranc factor and interacts with GPIb to induce platelet aggregation. Gastroenterol 2003;124:1983-1985.